Jeff Hanthorn

Jeff Hanthorn's Title

Jeff Hanthorn currently serves as the Chief Operating Officer (COO). In his role as COO, he is responsible for overseeing the daily operations of the company, ensuring efficiency and effectiveness in all areas of the business. His extensive background in various industries allows him to bring a wealth of experience and strategic insight to the executive team.

Jeff Hanthorn's Experience

With over 30 years of experience in healthcare, professional services, start-ups, HR, and business development, Jeff Hanthorn has built a diverse and robust career. He spent two decades at Eli Lilly and Company, where he honed his skills in various capacities, accumulating a wealth of knowledge in the healthcare sector. His experience spans multiple facets of business, making him a versatile leader.

Jeff Hanthorn's Role at Suros Surgical Systems, Inc.

Jeff Hanthorn served as the Vice President of Administration, Sales, and Operations at Suros Surgical Systems, Inc. In this role, he was instrumental in driving the company's growth and operational excellence. His leadership in sales and operations helped Suros Surgical Systems establish a strong market presence and achieve significant milestones in the medical device industry.

Jeff Hanthorn's Role at Revelant Technologies, LLC

As a Founding Partner at Revelant Technologies, LLC, Jeff Hanthorn played a crucial role in shaping the company's strategic direction and business development. His entrepreneurial spirit and innovative approach were pivotal in the establishment and growth of the company. Revelant Technologies benefited from his extensive experience in start-ups and professional services, enabling it to thrive in a competitive market.

Jeff Hanthorn's Board Membership at Corvida Medical

Jeff Hanthorn's tenure as a Board Member at Corvida Medical underscores his commitment to advancing healthcare solutions. His strategic insights and deep industry knowledge contributed to the company's efforts in developing innovative medical devices. His role on the board allowed him to influence key decisions and support the company in navigating the complexities of the healthcare market.